Sangui BioTech International, Inc. (SGBI: OTCQB) | DGAP-News: Sangui BioTech International Inc.: Revenues of USD 74,000 in fiscal year 2018; Introduction on the market of Granulox in Southeast Asia is proceeding according to plan; Foundation of Sangui Know-How - und Patentverwertungsgesellschaft mbH & Co.
(0)
(0)